Clinical Trial

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Study acronym: CAPSULE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated August 23, 2025 completion). Its status may not reflect the trial's current state.
Summary
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Trial Details
NCT Number NCT06885905
Lead Sponsor Imperial College London
Collaborators: Manchester University NHS Foundation Trust, Tayside Medical Science Centre
Conditions Chronic Pulmonary Aspergillosis
Enrollment 100 participants
Start Date 2024-11-27
Primary Completion 2025-08-23 (estimated)
Study Completion 2026-04-23 (estimated)
Updated on ClinicalTrials.gov 2025-03-20